Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
1998-09-03 to 1999-11-05
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: The study was conducted according to the appropriate OECD test guideline, and in compliance with GLP. Since this is a read-across from a structural analogue substance (CAS 6104-30-9), the reliability was set from RL1 to RL2.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1999
Report date:
1999

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Version / remarks:
(1997)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
Version / remarks:
(1992)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
HESSISCHES MINISTERIUM FÜR UMWELT, ENERGIE, JUGEND, FAMILIE UND GESUNDHEIT, Wiesbaden, Germany
Type of assay:
micronucleus assay

Test material

Constituent 1
Reference substance name:
N,N''-(isobutylidene)diurea
EC Number:
228-055-8
EC Name:
N,N''-(isobutylidene)diurea
Cas Number:
6104-30-9
IUPAC Name:
N,N''-(2-methylpropane-1,1-diyl)diurea
Details on test material:
- Name of test material (as cited in study report): Isobutylidenediurea (Isobutylidendiharnstoff BG-No. 204)
- Physical state: white powder
- Analytical purity: 90.1 weight %
- Lot/batch No.: 1/1/998
- Expiration date of the lot/batch: the stability of the test item over a period of 10 months was determined analytically
- Stability under test conditions: at least 3 h in 0.5% CMC (vehicle)
- Storage condition of test material: at room temperature
-Supplier: BASF AG, Ludwigshafen, Germany
- Date of synthesis: 1998-04-07

Test animals

Species:
mouse
Strain:
NMRI
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: BRL, Füllingsdorf, Switzerland
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 35.0±2.1 g
- Assigned to test groups randomly: yes (not further specified)
- Fasting period before study: 18 h
- Housing: individually in Makrolon Type I cages with wire mesh top (EHRET GmbH, Emmendingen, Germany), bedded with granulated soft wood (ALTROMIN, Lage/Lippe, Germany)
- Diet: pelleted standard diet (ALTROMIN, Lage/Lippe, Germany), ad libitum
- Water: tap water (Gemeindewerke, Roßdorf, Germany), ad libitum
- Acclimation period: at leaast 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21±3
- Humidity (%): 22-70
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
- Vehicle(s)/solvent(s) used: CMC (carboxymethyl cellulose)
- Justification for choice of solvent/vehicle: due to its non-toxicity to the animals
- Amount of vehicle (if gavage or dermal): 10 mL/kg bw (administered in two steps within 24 h)
- Purity: 0.5% aqueous suspension
Details on exposure:
PREPARATION OF DOSING SOLUTIONS:
The test susbtance was formulated in 0.5% CMC.
Duration of treatment / exposure:
24 h
Frequency of treatment:
two applications within 24 h
Post exposure period:
24 h
Doses / concentrations
Remarks:
Doses / Concentrations:
500, 1000, and 2000 mg/kg bw
Basis:
actual ingested
No. of animals per sex per dose:
6 males
Control animals:
yes, concurrent vehicle
Positive control(s):
CPA (cyclophosphamide)
- Analytical purity: at least 98%
- Supplier: SIGMA-Aldrich Vertriebs-GmbH, Deisenhofen, Germany
- Route of administration: single oral gavage
- Doses / concentrations: 40 mg/kg bw
- Volume administered: 10 mL/kg bw
- Vehicle: deionised water

Examinations

Tissues and cell types examined:
Tissue: bone marrow
Cell type: bone marrow cells
Details of tissue and slide preparation:
CRITERIA FOR DOSE SELECTION:
The doses applied were selected on the basis of the results of a preliminary acute toxicity study conducted with 3 males and 3 females at doses of 1000, 1500, and 2000 mg/kg bw. The experimental conditions concerning animals strain, vehicle, rout of exposure, frequency of administration, and application volume were the same in the toxicity pre-test as compared to the main genotoxicity study.

TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
The animals received a total of 10 mL/kg bw test material formulation via two oral gavages within a time period of 24 h. The animals were sacrificed 24 h after the last test material administration and submitted to the cell sampling procedure.

DETAILS OF SLIDE PREPARATION:
The slides were air-dried and then stained with May-Grünwald/Giemsa-solution. At least one slide was made from each bone marrow sample.

METHOD OF ANALYSIS:
The analysis was performed with coded slides using NIKON microscopes with 100x oil immersion objectives. At least 2000 polychromatic erythrocytes (PCE) were analysed per animal for micronuclei. To describe a cytotoxic effect the ratio between polychromatic and normochromatic erythrocytes was determined in the same sample and expressed as quotient PCE/NCE.
Evaluation criteria:
The study is considered valid as the following criteria are met:
- the vehcilce controls are in the range of the laboratorie's historical control data 0.04-0.16% PCEs with micronuclei (October 1997 - October 1998, males)
the positive controls show statistically significant increased values (historical range: 1.27-2.82% PCEs with micronuclei (October 1997 - October 1998, males)
- more than 80% of the animals are evaluable

A test article is classified as mutagenic if it induces either a dose-related increase in the number of micronucleated polychromatic erythrocytes or a statistically significant positive response for at least one of the test points.
A test article producing neither a dose-related increase in the number of micronucleated polychromatic erythrocytes nor a statistically significant positive response at any of the test points is considered non-mutagenic in this test system.
This can be confirmed by means of the non-parametric Whitney test. However, both biological and statistical significance should be considered together.
Statistics:
The non-parametric Mann-Whitney test was applied in this study.

Results and discussion

Test results
Sex:
male
Genotoxicity:
negative
Toxicity:
yes
Remarks:
2000 mg/kg bw (high dose) produced signs of toxicity
Vehicle controls validity:
valid
Negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
RESULTS OF RANGE-FINDING STUDY
- study type: acute toxicity study
- Dose range: 1000, 1500, and 2000 mg/kg bw
- Clinical signs of toxicity in test animals: reduction of spontaneous activity, eyelid closure, and apathy

RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei: no
- Ratio of PCE/NCE: no dose-related effect on the PCE/NCE ratio observed, which would indicate cytotoxicity
- Appropriateness of dose levels and route: yes (clinical signs of toxicity were observed, indicating systemic availability of the test article)
- Statistical evaluation: no statistically significant increase in micronucleated erythrocytes was observed using the non-parametric Mann-Whitney Test

Any other information on results incl. tables

Tab. 1: Summary of the Micronucleus Test Result (24 h sampling time)

Test group

Dose [mg/kg bw]

PCEs with micronuclei [%]

Range

PCE/NCE

Vehicle control

-

0.130

0-8

2000/1922

Test article

500

0.040

0-3

2000/1922

1000

0.090

0-3

2000/2217

2000

0.150

2-5

2000/2017

Positive control

40

1.45

16-46

2000/1996

Vehicle control: CMC (carboxymethyl cellulose), Positive control: CPA (cyclophosphamide)

PCE = polychromatic erythrocytes; NCE = normochromatic erythrocytes

Tab. 2: Results of the pre-experiment for toxicity

Toxic reactions

Hours after first gavage

Hours after second gavage

1 h

6 h

24 h

1 h

6 h

24 h

2000 mg/kg bw

Reduction of spontaneous activity*

2

3

3

3

3

3

Eyelid closure*

1

1

3

2

2

1

Apathy*

1

2

3

2

2

1

1500 mg/kg bw

Reduction of spontaneous activity (males/females)

2/1

3/3

3/3

3/3

3/3

2/3

Eyelid closure (males/females)

0/0

2/3

2/2

3/3

3/3

1/2

Apathy (males/females)

1/0

2/2

2/2

3/3

3/3

1/1

1000 mg/kg bw

Reduction of spontaneous activity (males/females)

1/2

3/3

3/3

3/3

3/3

3/3

3/3Eyelid closure (males/females)

0/0

2/3

3/3

2/2

3/3

1/2

Apathy (males/females)

0/0

2/2

3/3

2/2

2/3

1/1

* only males tested

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negative